{"id":"W1514929400","doi":"10.1002/ajh.23868","title":"A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Janssen Scientific Affairs; Leukemia and Lymphoma Society","keywords":"Medicine; Bortezomib; Internal medicine; Multiple myeloma; Gastroenterology; Neutropenia; Placebo; Dexamethasone; Refractory (planetary science); Discontinuation; Febrile neutropenia; Oncology; Toxicity; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001095325,0.0003752766,0.003949831,0.0007514489,0.0000715457,0.00001617378,0.0001898595,0.00009351531,0.00005419298],"category_scores_gemma":[0.001646937,0.0002205997,0.0002064545,0.0004183525,0.0006804059,0.0001638478,0.00006276562,0.0005240655,0.000004023971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009478705,"about_ca_system_score_gemma":0.000281901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000285836,"about_ca_topic_score_gemma":0.0002479942,"domain_scores_codex":[0.9960135,0.0008754429,0.001488641,0.0003820722,0.0007065739,0.0005338163],"domain_scores_gemma":[0.994571,0.002481275,0.00162201,0.0004241603,0.0004776136,0.0004239509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8365354,0.01014851,0.141386,0.00004585656,0.002243226,0.0007139295,0.000620532,0.000006240042,0.00006242277,0.00001335159,0.00002927249,0.008195267],"study_design_scores_gemma":[0.9326395,0.04543438,0.01814429,0.000155035,0.0008216206,0.0003306182,0.001578065,0.0005133652,0.0001662648,0.000006210502,0.0000267973,0.0001838156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964672,0.0002017633,0.00009002452,0.0001843931,0.0001109992,0.002812223,0.000008431402,0.00001331474,0.0001116976],"genre_scores_gemma":[0.998446,0.00008347663,0.001194711,0.00004641766,0.00004187151,0.0001059444,0.00001393583,0.00004502304,0.00002258751],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1232417,"threshold_uncertainty_score":0.8995793,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0191206186390491,"score_gpt":0.3177636878295063,"score_spread":0.2986430691904571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}